Skip to main content
12

Module 12 of 12

Surgical Complications: Prevention & Management

By Dr. Yehonatan Kaplan (M.D., Fellow ACMS)Published: 2026-03-10Updated: 2026-03-10Reviewed: 2026-03-10

Learning Objectives

  • Identify risk factors for and prevent postoperative hemorrhage and hematoma
  • Diagnose and manage surgical site infections and wound dehiscence
  • Recognize motor and sensory nerve injuries and understand prognosis for recovery
  • Manage flap and graft compromise with timely, appropriate interventions

Hemorrhagic Complications

Bleeding complications are the most common acute events after dermatologic surgery. They range from minor oozing to life-threatening hemorrhage. The vast majority are preventable with meticulous intraoperative hemostasis and appropriate perioperative anticoagulant management.

Intraoperative Hemorrhage

Effective hemostasis during Mohs surgery and excisional procedures relies on a layered approach combining mechanical, thermal, and chemical methods. Mechanical hemostasis: direct pressure is the first intervention for any bleeding. Apply firm, focal pressure with gauze for a minimum of 15–20 minutes by the clock (not estimated). Most small-vessel bleeding stops with pressure alone. Electrosurgery: electrocautery (monoterminal) and electrocoagulation (biterminal) are the workhorses of intraoperative hemostasis. Use the lowest effective power setting. Grasp the bleeding vessel with forceps and apply current to the forceps (indirect technique) for precise vessel sealing. Avoid wide-field fulguration near nerve structures. Chemical hemostasis: topical hemostatic agents supplement mechanical and thermal methods. Ligation: for named vessels (angular artery, superficial temporal artery), direct suture ligation with absorbable suture provides definitive hemostasis.

Important Warnings

  • Aluminum chloride and ferric subsulfate create histologic artifact and must NEVER be used during Mohs surgery while tissue is still being processed for margin assessment
Intraoperative Hemorrhage
AgentMechanismBest UseKey Considerations
Aluminum chloride (20–35%)Chemical cauterization; protein denaturationSuperficial oozing from dermis; biopsy sitesInterferes with histologic interpretation. Never use during Mohs tissue processing
Ferric subsulfate (Monsel’s)Chemical cauterization; iron-protein complex formationShave biopsy sites; post-curettage hemostasisCauses permanent tattoo artifact. Avoid on cosmetically sensitive areas
Absorbable gelatin (Gelfoam)Provides scaffold for clot formationDeep wound bed oozing; undermined spacesCan be saturated with thrombin for enhanced effect
Oxidized cellulose (Surgicel)Acidic pH promotes clot formation; bactericidalDeep surgical beds; irregular wound surfacesMay be left in wound; resorbs in 7–14 days
Topical thrombinConverts fibrinogen to fibrin directlyDiffuse oozing in anticoagulated patientsCan be combined with Gelfoam for synergistic effect
Tranexamic acid (topical)Antifibrinolytic; stabilizes formed clotsAdjunct in patients on anticoagulationApplied as soaked gauze; emerging evidence in dermatologic surgery

Postoperative Hematoma

Hematoma is the most common acute complication after Mohs surgery, occurring in 1–4% of cases. The risk is significantly elevated in patients on anticoagulant or antiplatelet therapy. Clinical presentation: progressive swelling, pain, and ecchymosis developing within the first 24–48 hours. Large hematomas cause tense, fluctuant swelling with violaceous discoloration. Expanding hematomas require urgent evaluation. Management algorithm: • Small, stable hematoma (non-expanding): observation, ice application, pressure dressing. Most small hematomas resorb spontaneously over 1–2 weeks. • Large or expanding hematoma: requires evacuation. Open a portion of the wound (remove select sutures), evacuate the clot with irrigation, identify and cauterize the bleeding source, re-close, and apply a pressure dressing. • Hematoma under a flap: urgent evacuation is critical. Pressure from the hematoma compromises flap perfusion and can cause flap necrosis. Open, evacuate, achieve hemostasis, and re-secure the flap. • Hematoma under a graft: aspirate or evacuate through a fenestration; re-apply bolster. Hematoma is the most common cause of graft failure.

Key Points

  • The most important preventive measure is meticulous intraoperative hemostasis. Check hemostasis with the patient sitting upright (increased venous pressure) before closing
  • Having the patient perform a Valsalva maneuver before closure helps identify venous bleeding that may not be apparent in the supine position
  • An expanding hematoma under a flap is a surgical emergency. Delay in evacuation risks flap loss from vascular compromise

Infectious & Wound Healing Complications

Surgical site infections (SSI) after dermatologic surgery are uncommon (overall rate 1–3%) but can cause significant morbidity including wound dehiscence, tissue necrosis, and poor cosmetic outcomes.

Surgical Site Infection

SSI in dermatologic surgery is classified by timing and depth: Superficial incisional SSI: involves skin and subcutaneous tissue within 30 days of surgery. Presents with erythema, warmth, swelling, purulent drainage, and pain. Deep incisional SSI: involves fascia or muscle layers. Uncommon in typical Mohs procedures but possible in deep excisions. Risk factors for SSI after dermatologic surgery:

Clinical Pearls

  • The overall SSI rate for Mohs surgery is low (1–3%). Routine prophylactic antibiotics are NOT recommended for clean surgical wounds on the head and neck
  • The anatomic sites with highest SSI rates are: below the knee > groin/perineal > ear > lip > nose. The forehead and scalp have the lowest SSI rates due to excellent blood supply
  • Most SSIs after dermatologic surgery are caused by Staphylococcus aureus. Cephalexin 500mg QID for 7–10 days is appropriate empiric therapy for uncomplicated SSI
Surgical Site Infection
Risk FactorRelative RiskMitigation Strategy
Location below the knee3–5x baselineProphylactic antibiotics for wedge excisions; meticulous sterile technique
Groin/perineal location3–4x baselineProphylactic antibiotics recommended; consider delayed closure
Skin graft or flap repair2–3x baselineMeticulous hemostasis; sterile technique; bolster dressing
Diabetes mellitus2–3x baselineOptimize glycemic control perioperatively (target glucose < 200 mg/dL)
Anticoagulant therapyIndirect (via hematoma)Minimize dead space; pressure dressing; hemostatic agents
Contaminated wound (lip, ear canal)2–3x baselineConsider prophylactic antibiotics; delayed closure if heavily contaminated
Immunosuppression2–5x baselineLower threshold for prophylactic antibiotics; close follow-up

Wound Dehiscence

Wound dehiscence is partial or complete separation of the wound edges after closure. It is the second most common complication after hemorrhage. Causes of dehiscence: • Excessive wound tension (most common cause). Inadequate undermining, insufficient deep sutures, or closure under tension • Infection. Purulent material undermines wound adhesion • Hematoma/seroma. Fluid collection separates wound edges • Premature suture removal. Before adequate tensile strength develops • Patient non-compliance. Premature activity, trauma to wound Management: small dehiscences (< 50% of wound length) can often heal by secondary intention with excellent cosmetic results, particularly on concave surfaces. Large dehiscences may require re-closure (delayed primary closure) or revision after healing is complete. For dehiscence caused by infection: open the wound completely, irrigate, initiate antibiotics, and allow healing by secondary intention. Do NOT re-close an infected wound.

Important Warnings

  • An infected dehiscence must NOT be re-closed. Closing a contaminated wound traps bacteria and converts a manageable superficial infection into a deep tissue infection or abscess

Tissue Necrosis

Tissue necrosis after flap surgery results from inadequate blood supply to the transferred tissue. It is more common in random pattern flaps where the length-to-width ratio is excessive or the pedicle vasculature is compromised. Risk factors for flap necrosis: • Excessive flap length-to-width ratio (>3:1 for random pattern flaps) • Smoking. Nicotine causes vasoconstriction and reduces tissue oxygenation • Excessive tension at the flap tip • Hematoma under the flap • Prior radiation to the surgical site • Peripheral vascular disease / diabetes Early signs: dusky discoloration (blue/purple) at the flap tip, cool temperature, delayed capillary refill, and progressive darkening. These signs typically appear within 24–72 hours. Management: if caught early, relieve all tension (remove some sutures), evacuate any hematoma, and optimize blood flow (warmth, stop vasoconstrictors). If necrosis is established, allow demarcation over 1–2 weeks, then debride necrotic tissue and allow healing by secondary intention or perform revision.

Clinical Pearls

  • Distal flap tip necrosis is the most common pattern. The tip has the most tenuous blood supply. Prevent by avoiding excessive tension at the flap tip and ensuring an adequate pedicle width
  • Smoking cessation for at least 4 weeks before and after surgery significantly reduces flap necrosis risk. Counsel patients preoperatively

Neurologic & Structural Complications

Nerve injury is a recognized risk of dermatologic surgery, particularly in the danger zones of the face where motor nerve branches are superficial. Structural complications include free margin distortion and cartilage exposure.

Motor Nerve Injury

The facial nerve (CN VII) is the most commonly injured motor nerve during cutaneous surgery. The temporal and marginal mandibular branches are at greatest risk because of their superficial course. Danger zones for motor nerve injury:

Key Points

  • The temporal branch is most vulnerable at the temple where it travels within or just deep to the SMAS/temporoparietal fascia. Staying superficial to the deep temporal fascia during undermining protects this nerve
  • Most motor nerve injuries in dermatologic surgery are neuropraxia (stretch/compression injury). 90% recover full function within 3–6 months without intervention
  • If a motor nerve is transected during Mohs surgery, primary nerve repair (epineural microsuture) should be performed if the nerve ends can be identified. This is best done by a microsurgeon within 72 hours

Important Warnings

  • Any patient presenting with new motor deficit after cutaneous surgery on the temple, jawline, or posterior neck should be assumed to have nerve injury until proven otherwise. Document the deficit immediately and arrange appropriate follow-up or surgical consultation
Motor Nerve Injury
Nerve BranchDanger ZoneDepth of RiskClinical Deficit if Injured
Temporal branch (CN VII)Temple. From zygomatic arch to lateral forehead; within the ‘Pitanguy line’ (tragus to lateral eyebrow)Superficial to deep temporal fascia (within SMAS/temporoparietal fascia)Inability to raise eyebrow; frontalis paralysis; brow ptosis
Marginal mandibular (CN VII)Jawline. Crosses mandible 1–2cm below mandibular border; superficial to facial vesselsSuperficial at mandibular angle; deep to platysmaInability to depress lower lip; asymmetric smile
Spinal accessory (CN XI)Posterior triangle of neck. Emerges at Erb’s point, crosses posterior triangle superficiallyWithin subcutaneous tissue of posterior neck triangleShoulder drop; trapezius weakness; inability to shrug shoulder

Sensory Nerve Injury

Sensory nerve injury is more common than motor nerve injury after dermatologic surgery but causes less functional morbidity. Transient numbness or paresthesia is expected after any procedure involving undermining. Commonly affected sensory nerves: • Supraorbital / supratrochlear (CN V1): forehead and anterior scalp numbness after forehead/glabella surgery • Infraorbital (CN V2): cheek, upper lip, and lateral nose numbness after midface surgery • Mental nerve (CN V3): lower lip and chin numbness after mandibular area surgery • Great auricular nerve: ear and periauricular numbness after neck/ear surgery Prognosis: most sensory nerve injuries recover within 3–12 months as nerve regeneration occurs at approximately 1mm per day. Complete division of a major sensory nerve trunk causes permanent anesthesia in its distribution.

Clinical Pearls

  • Warn patients preoperatively about expected temporary numbness after procedures involving undermining. This is a normal consequence of transecting small sensory nerve branches, not a complication
  • The infraorbital nerve is at greatest risk during deep nasolabial fold or cheek surgery. It exits the infraorbital foramen approximately 1cm below the infraorbital rim in the mid-pupillary line

Free Margin Distortion

Distortion of free margins (eyelid, nasal alar rim, lip) is a functional and cosmetic complication caused by excessive tension directed toward the free margin during wound closure. Prevention strategies: • Visualize tension vectors before incision. Ensure the primary closing force does not pull directly on a free margin • Choose flap designs that redirect tension AWAY from the nearest free margin • Wide undermining to distribute tension broadly rather than concentrating it at the margin • Anchor deep sutures to periosteum or fixed tissues to redirect tension • Consider staged repairs or grafts for defects where no flap orientation can avoid margin distortion Management: mild distortion often improves as wound contraction and remodeling occur over 3–6 months. Significant distortion (functional impairment) may require scar revision, Z-plasty, or secondary reconstruction after wound maturation.

Key Points

  • Ectropion (eyelid eversion) is the most feared free margin distortion. Always direct closing tension laterally or superiorly, NEVER inferiorly when repairing lower eyelid and cheek defects
  • Alar rim retraction or notching can be prevented by ensuring flap designs for nasal ala defects do not place inferior traction on the alar rim
References
  1. [1] Complications of dermatologic surgery: A review of the literature. J Am Acad Dermatol. . doi:10.1016/j.jaad.2021.05.049
  2. [2] Surgery of the Skin: Procedural Dermatology, 3rd Edition. Elsevier. .
  3. [3] NCCN Clinical Practice Guidelines in Oncology: Basal Cell Skin Cancer v1.2026. NCCN Guidelines. .
  4. [4] NCCN Clinical Practice Guidelines in Oncology: Squamous Cell Skin Cancer v1.2026. NCCN Guidelines. .
  5. [5] Facial Nerve Danger Zones. Plast Reconstr Surg. . doi:10.1097/PRS.0000000000006401

About This Article

Author: , Fellow ACMS

Last Medical Review:

Audience: Dermatologic Surgeons

Clinic: Kaplan Clinic · DermUnbound Research Program

Educational content only. This material does not replace hands-on training, mentorship, or institutional protocols. All clinical decisions remain the responsibility of the treating physician.